Analysis of Body Mass Index in Central Precocious Puberty Patients Treated With Leuprolide Acetate
NCT02974270 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 100
Last updated 2016-11-28
Summary
Analysis of body mass index in Central Precocious Puberty patients treated with leuprolide acetate
Conditions
- Precocious Puberty, Central
Interventions
- DRUG
-
Leuprolide
Sponsors & Collaborators
-
Kyungpook National University Hospital
lead OTHER
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Max Age
- 9 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2016-06-30
- Primary Completion
- 2018-03-31
Countries
- South Korea
Study Locations
More Related Trials
-
Location of GLP-1 Release
NCT02036710 ·Status: COMPLETED
-
Blocking of the Gut Hormone Receptor for Glucagon-like Peptide 2 (GLP-2) by the GLP-2 Receptor Antagonist GLP-2(3-33)
NCT06774807 ·Status: COMPLETED ·Phase: NA
-
The Effect of Liraglutide on the GIT
NCT04008290 ·Status: UNKNOWN ·Phase: PHASE4
-
Effect of Liraglutide on Fatty Liver Content and Lipoprotein Metabolism
NCT02721888 ·Status: TERMINATED ·Phase: PHASE4
-
Effects of Single Doses of Liraglutide and Dapagliflozin on Ketogenesis in Type 1 Diabetes
NCT02777073 ·Status: COMPLETED ·Phase: NA
-
Targeting Beta-cell Failure in Lean Patients With Type 2 Diabetes
NCT04657939 ·Status: COMPLETED ·Phase: PHASE4
-
Liraglutide in Type 1 Diabetes
NCT01612468 ·Status: COMPLETED ·Phase: PHASE4
-
Effects of Glucagon Like Peptide-1 on Haemodynamic Parameters
NCT02490176 ·Status: UNKNOWN ·Phase: NA
-
Blood Pressure Outcomes With Liraglutide Therapy
NCT01755572 ·Status: COMPLETED ·Phase: PHASE4
-
Antrum Size, Glucagon-like Peptide 1 Levels and Glycemic Control After Sleeve Gastrectomy in Morbid Obese Diabetic Adolescents
NCT04388059 ·Status: COMPLETED
-
The Effect of Liraglutide on Bone Turnover, Bone Mass and Bone Cell Function
NCT02473809 ·Status: COMPLETED ·Phase: PHASE4
-
GLP-1 and Non-exercise Activity Thermogenesis in RHZ
NCT01638260 ·Status: TERMINATED ·Phase: PHASE4
-
Investigation of the Relationship Between Peripheral and Central Metabolic Changes Induced by GLP-1 Agonists
NCT06818292 ·Status: COMPLETED ·Phase: NA
-
Effects of Antagonizing the Ghrelin Receptor on Brain Food Cue Reactivity in Obesity
NCT06845033 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Effects of Glucagon Like Peptide-1(GLP-1) and Liraglutide on Brain Satiety and Reward Circuits and Feeding Behavior in Diabetes
NCT01363609 ·Status: COMPLETED ·Phase: NA
-
Body Mass Index and Growth Parameters Evolution in Children Treated With Hybrid Closed Loop System for Type 1 Diabetes
NCT06185348 ·Status: NOT_YET_RECRUITING
-
Leptin to Treat Severe Insulin Resistance - Pilot Study
NCT00027456 ·Status: COMPLETED ·Phase: PHASE2
-
The Effect of Semaglutide on Pituitary Function
NCT04865744 ·Status: COMPLETED ·Phase: PHASE4
-
Combined Liraglutide and Metformin Therapy in Women With Previous Gestational Diabetes Mellitus (GDM)
NCT01234649 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of a GLP-1 Receptor Agonist on Functional Activation and Connectivity of the Brain
NCT02745470 ·Status: COMPLETED ·Phase: NA
-
Investigating Glucose Metabolism of LEAP2 With Total-body PET/CT
NCT06254365 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Liraglutide as Additional Treatment in Patients With Type 1 Diabetes Mellitus
NCT01299012 ·Status: COMPLETED
-
Liraglutide in Newly Onset Type 1 Diabetes.
NCT01879917 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effects of GLP-1 on Chronic Heart Failure
NCT02650596 ·Status: UNKNOWN ·Phase: NA
-
52 Week Trial of Liraglutide in Type 1 Diabetes
NCT01787916 ·Status: COMPLETED ·Phase: PHASE4